{ "cik": 1346830, "cik_padded": "0001346830", "entityName": "Tvardi Therapeutics, Inc.", "fiscal_years": [ { "accn": "0001104659-26-037729", "filed": "2026-03-31", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "cash": "USD", "eps_diluted": "USD/shares", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "cash": 20734000.0, "eps_diluted": -3.26, "net_income": -18214000.0, "operating_cash_flow": -23499000.0, "operating_income": -26748000.0, "stockholders_equity": 20946000.0, "total_assets": 32073000.0, "total_liabilities": 11127000.0 }, "period_end": "2025-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.531223145230593, "roa_avg2y": -0.5415031513854204, "roa_period_end": -0.5678919963832507, "roe_avg2y": 0.5190282823965234, "roe_period_end": -0.8695693688532417 } }, { "accn": "0001104659-26-037729", "filed": "2026-03-31", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 1046000.0, "cash": 31614000.0, "eps_diluted": -11.42, "free_cash_flow": -19351000.0, "net_income": -29397000.0, "operating_cash_flow": -18305000.0, "operating_income": -28107000.0, "stockholders_equity": -91131000.0, "total_assets": 35199000.0, "total_liabilities": 40827000.0 }, "period_end": "2024-12-31", "ratio_units": { "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "roa_avg2y": -0.3650826176859597, "roa_period_end": -0.8351657717548794, "roe_avg2y": 0.3838004034232223 } }, { "accn": "0001104659-26-037729", "filed": "2026-03-31", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 2375000.0, "cash": 51775000.0, "eps_diluted": -26.26, "free_cash_flow": -94453000.0, "net_income": -118513000.0, "operating_cash_flow": -92078000.0, "operating_income": -121495000.0, "stockholders_equity": -62058000.0, "total_assets": 125844000.0, "total_liabilities": 68759000.0 }, "period_end": "2023-12-31", "ratio_units": { "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "roa_avg2y": -0.7693626026921492, "roa_period_end": -0.9417453354947395, "roe_avg2y": -2.4506156884234036 } }, { "accn": "0001558370-25-002705", "filed": "2025-03-11", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 43000.0, "cash": 63741000.0, "eps_diluted": -19.12, "free_cash_flow": -78773000.0, "net_income": -85474000.0, "operating_cash_flow": -78730000.0, "operating_income": -87535000.0, "stockholders_equity": 158779000.0, "total_assets": 182237000.0, "total_liabilities": 23458000.0 }, "period_end": "2022-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.14773994042033267, "roa_avg2y": -0.39820821676570545, "roa_period_end": -0.46902659723327317, "roe_avg2y": -0.4425253882335277, "roe_period_end": -0.5383205587640683 } }, { "accn": "0001558370-25-002705", "filed": "2025-03-11", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD" }, "fundamentals": { "capex": 39000.0, "cash": 13453000.0, "eps_diluted": -1.74, "free_cash_flow": -60126000.0, "net_income": -88441000.0, "operating_cash_flow": -60087000.0, "operating_income": -89083000.0, "stockholders_equity": 227522000.0, "total_assets": 247056000.0 }, "period_end": "2021-12-31", "ratio_units": { "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "roa_avg2y": -0.34133068834629776, "roa_period_end": -0.35797956738553205, "roe_avg2y": -0.3711929959309414, "roe_period_end": -0.38871405842072415 } }, { "accn": "0001558370-24-002609", "filed": "2024-03-06", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD" }, "fundamentals": { "capex": 349000.0, "cash": 31683000.0, "eps_diluted": 0.18, "free_cash_flow": -5836000.0, "net_income": 8410000.0, "operating_cash_flow": -5487000.0, "operating_income": 5385000.0, "stockholders_equity": 249001000.0, "total_assets": 271157000.0 }, "period_end": "2020-12-31", "ratio_units": { "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "roa_avg2y": 0.03336533654952432, "roa_period_end": 0.031015242092219637, "roe_avg2y": 0.03860330400216656, "roe_period_end": 0.03377496475917768 } }, { "accn": "0001558370-23-002913", "filed": "2023-03-06", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD" }, "fundamentals": { "capex": 18000.0, "cash": 18305000.0, "eps_diluted": -2.49, "free_cash_flow": -109243000.0, "net_income": -106373000.0, "operating_cash_flow": -109225000.0, "operating_income": -111679000.0, "stockholders_equity": 186713000.0, "total_assets": 232959000.0 }, "period_end": "2019-12-31", "ratio_units": { "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "roa_avg2y": -0.502017546757531, "roa_period_end": -0.4566168295708687, "roe_avg2y": -0.6641193970213177, "roe_period_end": -0.5697139460026887 } }, { "accn": "0001558370-22-002555", "filed": "2022-03-01", "fiscal_year": 2018, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD" }, "fundamentals": { "capex": 73000.0, "cash": 15081000.0, "eps_diluted": -2.06, "free_cash_flow": -22374000.0, "net_income": -74013000.0, "operating_cash_flow": -22301000.0, "operating_income": -77382000.0, "stockholders_equity": 133630000.0, "total_assets": 190823000.0 }, "period_end": "2018-12-31", "ratio_units": { "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "roa_avg2y": -0.5142880966691797, "roa_period_end": -0.3878620501721491, "roe_avg2y": -0.6715938478290459, "roe_period_end": -0.5538651500411584 } }, { "accn": "0001558370-21-001839", "filed": "2021-02-25", "fiscal_year": 2017, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD" }, "fundamentals": { "capex": 58000.0, "cash": 9388000.0, "free_cash_flow": -54885000.0, "net_income": -58125000.0, "operating_cash_flow": -54827000.0, "operating_income": -59485000.0, "stockholders_equity": 86780000.0, "total_assets": 97004000.0 }, "period_end": "2017-12-31", "ratio_units": { "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "roa_avg2y": -0.7228039196179865, "roa_period_end": -0.599202094758979, "roe_avg2y": -0.8454238027708083, "roe_period_end": -0.6697971882922331 } }, { "accn": "0001564590-19-007389", "filed": "2020-02-27", "fiscal_year": 2016, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD" }, "fundamentals": { "capex": 717000.0, "cash": 12092000.0, "free_cash_flow": -48098000.0, "net_income": -57280000.0, "operating_cash_flow": -47381000.0, "operating_income": -58400000.0, "stockholders_equity": 50725000.0, "total_assets": 63828000.0 }, "period_end": "2016-12-31", "ratio_units": { "roa_period_end": "ratio", "roe_period_end": "ratio" }, "ratios": { "roa_period_end": -0.8974117941969042, "roe_period_end": -1.1292262198127156 } }, { "accn": "0001564590-18-005879", "filed": "2018-03-15", "fiscal_year": 2015, "form": "10-K", "fundamental_units": { "capex": "USD" }, "fundamentals": { "capex": 20000.0 }, "period_end": "2015-12-31", "ratios": {} } ], "latest_filing": { "accn": "0001104659-26-037729", "filed": "2026-03-31", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "2834", "sic_description": "Pharmaceutical Preparations", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001346830.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0001346830.json" }, "ticker": "TVRD" }